CR9385A - Agente preventivo o terapeutico para el desorden de la depresion o la ansiedad - Google Patents
Agente preventivo o terapeutico para el desorden de la depresion o la ansiedadInfo
- Publication number
- CR9385A CR9385A CR9385A CR9385A CR9385A CR 9385 A CR9385 A CR 9385A CR 9385 A CR9385 A CR 9385A CR 9385 A CR9385 A CR 9385A CR 9385 A CR9385 A CR 9385A
- Authority
- CR
- Costa Rica
- Prior art keywords
- depression
- anxiety
- preventive
- disorder
- therapeutic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se pretende proveer una medida preventiva o remedio para neurosis por depresion o ansiedad que contiene (S)-N-[2-(1,6,7,8-tetrahidro-2H-inden[5,4-b] furan-8-il)etil]propionamida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005107674 | 2005-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR9385A true CR9385A (es) | 2007-12-07 |
Family
ID=37073564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR9385A CR9385A (es) | 2005-04-04 | 2007-09-18 | Agente preventivo o terapeutico para el desorden de la depresion o la ansiedad |
Country Status (23)
Country | Link |
---|---|
US (1) | US20090042861A1 (es) |
EP (1) | EP1867641A4 (es) |
JP (1) | JP5259181B2 (es) |
KR (1) | KR20070118103A (es) |
CN (1) | CN101189219A (es) |
AR (1) | AR054435A1 (es) |
AU (1) | AU2006231752B2 (es) |
BR (1) | BRPI0607684A2 (es) |
CA (1) | CA2602267A1 (es) |
CL (1) | CL2009000980A1 (es) |
CR (1) | CR9385A (es) |
GE (1) | GEP20105001B (es) |
IL (1) | IL186049A0 (es) |
MA (1) | MA29677B1 (es) |
MY (1) | MY142214A (es) |
NO (1) | NO20075599L (es) |
NZ (1) | NZ561677A (es) |
PE (1) | PE20061355A1 (es) |
RU (1) | RU2413510C2 (es) |
TW (1) | TWI391132B (es) |
UA (1) | UA89397C2 (es) |
WO (1) | WO2006107019A1 (es) |
ZA (1) | ZA200708445B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101983193B (zh) * | 2008-01-31 | 2014-03-12 | 武田药品工业株式会社 | 注意缺陷/多动障碍的预防或治疗剂 |
AR084865A1 (es) * | 2011-01-17 | 2013-07-10 | Takeda Pharmaceutical | Preparacion de desintegracion rapida, comprimido dispersable por via oral |
US8426461B2 (en) | 2011-01-17 | 2013-04-23 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
EP2765985A1 (en) * | 2011-10-14 | 2014-08-20 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
CN102718675B (zh) * | 2012-06-07 | 2015-03-25 | 上海右手医药科技开发有限公司 | 阿戈美拉汀甲磺酸复合物及其制备方法 |
RU2571546C1 (ru) * | 2014-07-14 | 2015-12-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации | Способ дифференцированной диагностики и терапии синдрома ночной еды |
CA3058507A1 (en) | 2017-03-30 | 2018-10-04 | Jose Eduardo Penello Temporao | Multivitamin composition for improving verbal fluency, decreasing performance anxiety symptoms and method for preparing same |
CN108451917A (zh) * | 2018-03-22 | 2018-08-28 | 仁和堂药业有限公司 | 高稳定性米安色林制剂的制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4241013A1 (de) * | 1992-12-05 | 1994-06-09 | Boehringer Ingelheim Kg | Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung |
DE69524871T2 (de) * | 1994-06-10 | 2002-08-22 | Smithkline Beecham Plc | Benzopyrans und deren verwendung als therapeutische mittel |
US5780470A (en) * | 1995-06-02 | 1998-07-14 | Bristol-Myers Squibb Company | Melatonergic indanyl piperazines |
US6034239A (en) * | 1996-03-08 | 2000-03-07 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
NZ330656A (en) * | 1996-03-08 | 1999-06-29 | Takeda Chemical Industries Ltd | Tricyclic compounds, their production and use |
JP2884153B2 (ja) * | 1996-03-08 | 1999-04-19 | 武田薬品工業株式会社 | 三環性化合物、その製造法および剤 |
WO1999063977A2 (en) * | 1998-06-09 | 1999-12-16 | Takeda Chemical Industries, Ltd. | Pharmaceutical combination comprising a tricyclic compound and at least one of zolpidem, zopiclone, triazolam and brotizolam for treating or preventing sleep disorders |
JP3509637B2 (ja) * | 1998-06-09 | 2004-03-22 | 武田薬品工業株式会社 | 睡眠障害予防治療剤 |
EE200200717A (et) * | 2000-06-27 | 2004-08-16 | Taisho Pharmaceutical Co., Ltd. | Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid |
US6589978B2 (en) * | 2000-06-30 | 2003-07-08 | Hoffman-La Roche Inc. | 1-sulfonyl pyrrolidine derivatives |
US6569887B2 (en) * | 2001-08-24 | 2003-05-27 | Dov Pharmaceuticals Inc. | (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake |
JP2005516891A (ja) * | 2001-09-13 | 2005-06-09 | シェーリング コーポレイション | アデノシンA2aレセプタアンタゴニストと抗鬱薬または抗不安薬との組合せ |
US20070088079A1 (en) * | 2005-09-20 | 2007-04-19 | Takeda Pharmaceutical Company Limited | Prophylactic or therapeutic agent for sleep disorder |
-
2006
- 2006-04-03 CA CA002602267A patent/CA2602267A1/en not_active Abandoned
- 2006-04-03 TW TW095111740A patent/TWI391132B/zh not_active IP Right Cessation
- 2006-04-03 JP JP2007511227A patent/JP5259181B2/ja not_active Expired - Fee Related
- 2006-04-03 US US11/918,034 patent/US20090042861A1/en not_active Abandoned
- 2006-04-03 BR BRPI0607684-0A patent/BRPI0607684A2/pt not_active IP Right Cessation
- 2006-04-03 AU AU2006231752A patent/AU2006231752B2/en not_active Ceased
- 2006-04-03 KR KR1020077022636A patent/KR20070118103A/ko not_active Application Discontinuation
- 2006-04-03 MY MYPI20061491A patent/MY142214A/en unknown
- 2006-04-03 CN CNA2006800197795A patent/CN101189219A/zh active Pending
- 2006-04-03 RU RU2007140986/15A patent/RU2413510C2/ru not_active IP Right Cessation
- 2006-04-03 AR ARP060101310A patent/AR054435A1/es not_active Application Discontinuation
- 2006-04-03 ZA ZA200708445A patent/ZA200708445B/xx unknown
- 2006-04-03 UA UAA200710985A patent/UA89397C2/ru unknown
- 2006-04-03 WO PCT/JP2006/307047 patent/WO2006107019A1/ja active Application Filing
- 2006-04-03 EP EP06730995A patent/EP1867641A4/en not_active Withdrawn
- 2006-04-03 GE GEAP200610302A patent/GEP20105001B/en unknown
- 2006-04-03 NZ NZ561677A patent/NZ561677A/en not_active IP Right Cessation
- 2006-04-03 PE PE2006000359A patent/PE20061355A1/es not_active Application Discontinuation
-
2007
- 2007-09-18 IL IL186049A patent/IL186049A0/en unknown
- 2007-09-18 CR CR9385A patent/CR9385A/es unknown
- 2007-10-25 MA MA30311A patent/MA29677B1/fr unknown
- 2007-11-05 NO NO20075599A patent/NO20075599L/no not_active Application Discontinuation
-
2009
- 2009-04-24 CL CL2009000980A patent/CL2009000980A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
TWI391132B (zh) | 2013-04-01 |
MA29677B1 (fr) | 2008-08-01 |
PE20061355A1 (es) | 2007-01-15 |
ZA200708445B (en) | 2009-03-25 |
AU2006231752A1 (en) | 2006-10-12 |
GEP20105001B (en) | 2010-06-10 |
MY142214A (en) | 2010-11-15 |
NZ561677A (en) | 2011-02-25 |
RU2413510C2 (ru) | 2011-03-10 |
AR054435A1 (es) | 2007-06-27 |
NO20075599L (no) | 2007-12-19 |
TW200719885A (en) | 2007-06-01 |
EP1867641A1 (en) | 2007-12-19 |
US20090042861A1 (en) | 2009-02-12 |
KR20070118103A (ko) | 2007-12-13 |
AU2006231752B2 (en) | 2012-03-01 |
WO2006107019A1 (ja) | 2006-10-12 |
CN101189219A (zh) | 2008-05-28 |
JPWO2006107019A1 (ja) | 2008-09-25 |
CA2602267A1 (en) | 2006-10-12 |
IL186049A0 (en) | 2008-02-09 |
UA89397C2 (ru) | 2010-01-25 |
CL2009000980A1 (es) | 2009-08-14 |
JP5259181B2 (ja) | 2013-08-07 |
RU2007140986A (ru) | 2009-05-20 |
BRPI0607684A2 (pt) | 2009-09-22 |
EP1867641A4 (en) | 2010-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR9385A (es) | Agente preventivo o terapeutico para el desorden de la depresion o la ansiedad | |
ECSP11010975A (es) | Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales | |
BRPI0921830A8 (pt) | Composição para tratamento bucal compreendendo sílica fundida | |
IS8505A (is) | (S)-2-N-própýlamínó-5-hýdroxýetralín sem D3-gerandefni | |
CL2018001420A1 (es) | Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma. (divisional solicitud 201701853) | |
CR10245A (es) | "nuevas combinaciones terapéuticas para el tratamiento de la depresión" | |
ES2564172T3 (es) | Utilización de una composición cosmética para el cuidado de las pieles grasas | |
MY155317A (en) | Benzene sulfonamide thiazole and oxazole compounds | |
BRPI0609711B8 (pt) | uso de uma solução aquosa com potencial redutivo oxidativo (orp) | |
BRPI0508051A (pt) | derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes | |
MY148459A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression | |
GT200500309A (es) | Derivados de sulfonilbencilimidazol | |
DOP2011000249A (es) | Compuesto de anillo fusionado y su uso | |
AR109263A2 (es) | Composición que comprende moxidectina | |
CL2007003643A1 (es) | Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas. | |
UY31133A1 (es) | "oxazolidinonas sustituidas y su uso" | |
CL2008001990A1 (es) | Compuestos derivados de amino-quinazolinas sustituidas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de alzheimer. | |
UY30675A1 (es) | Metodos para el tratamiento de la depresion | |
CR10255A (es) | "nuevas composiciones terapéuticas para el tratamiento o la prevención de trastornos psicóticos" | |
BRPI0713743C1 (pt) | composto, e, composição farmacêutica | |
CL2007003043A1 (es) | Compuestos derivados de cromano; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y ansiedad entre otros. | |
BRPI0519006A2 (pt) | uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos | |
BRPI0411175A (pt) | combinação do modafinil analéptico e um antidepressivo para o tratamento da depressão | |
BRPI0411174A (pt) | combinação do modafinil analéptico e um antidepressivo para o tratamento da depressão | |
CL2007003396A1 (es) | Uso de agomelatina o n-[2-(7-metoxi-1-naftil)etil]acetamida para el tratamiento del sindrome de smith magenis; composicion farmaceutica que contiene agomelatina. |